Skip to main content
Clinical Trials/NCT02325388
NCT02325388
Completed
Not Applicable

Effectiveness of a Pressure-sensing System to Reduce the Risk of Pressure Ulcer Formation by Lowering Interface Pressure in Vulnerable Patient Populations: A Parallel-two-group Randomized Controlled Trial

University of Calgary1 site in 1 country678 target enrollmentDecember 2014
ConditionsPressure Ulcer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pressure Ulcer
Sponsor
University of Calgary
Enrollment
678
Locations
1
Primary Endpoint
Interface pressure analysis - sensel pressure reading
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Pressure ulcers are prevalent conditions that result in substantial financial costs to the healthcare system as well as significant distress to affected patients and their families. This study is a parallel two-group randomized controlled trial that aims to study how the use of a pressure sensing device with continuous visual feedback of pressure imaging may potentially decrease the interface pressure of patients who are at risk of pressure ulcers in an acute hospital setting.

Detailed Description

Background: Pressure ulcers result in substantial financial costs to the healthcare system as well as significant distress to affected patients and their families. As interface pressure is a key risk factor in the development of pressure ulcers, continuous visual feedback of continuous pressure imaging (CPI) between the body and support surface could inform healthcare providers on repositioning strategies and play a key role in an overall strategy for the prevention and management of pressure ulcers. This randomized, controlled trial aims to study the effect of CPI on the reduction of interface pressure, and the incidence of pressure ulcers in vulnerable hospital patients. Methods: A parallel two-group randomized controlled clinical trial will be conducted. A total of 678 eligible consenting inpatients at high risk of pressure ulcer development in a tertiary acute care institution will be randomly allocated to either have the ForeSite PT™ system with the liquid-crystal display ("LCD") monitor turned on to provide visual feedback through CPI to healthcare providers while also collecting continuous interface pressure data (intervention group), or have the ForeSite PT™ system with the LCD monitor turned off, therefore not providing visual feedback or CPI to healthcare providers, while collecting continuous interface pressure data in the background (control group), in a ratio of 1:1. Data will be collected on both groups for three days (72 hours). The primary outcome will be the differences in the two groups' interface pressure analysis. The interface pressure readings will be collected through hourly sampling of continuous interface pressure recordings taken throughout this study period. Clinical outcomes will be the differences in the two groups' pressure-related skin and soft tissue change in areas at risk of pressure ulcer. It will be obtained at baseline (within 24 hours of admission) and on the third day of the trial. Perceptions of intervention patients and healthcare providers will be obtained on the third day. Discussion: This will be the first randomized controlled trial to investigate the effect of CPI on interface pressure of vulnerable hospital patients, and the association between interface pressure and development of pressure-related skin and soft tissue changes. The results could provide important information to guide clinical practice in the prevention and management of pressure ulcers.

Registry
clinicaltrials.gov
Start Date
December 2014
End Date
May 10, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chester Ho, MD

Associate Professor

University of Calgary

Eligibility Criteria

Inclusion Criteria

  • Adult, man or woman, with a minimum age limit of 18 years old.
  • Expected to have a length of stay on the unit of at least three days.
  • Require assistance with bed mobility or completely dependent for bed mobility as determined by the "Bed" components in the de Morton Mobility Index (DEMMI). Eligible patients would be:
  • Unable (score of "0") to bridge, roll onto their side, and sit from lying supine.
  • Unable (score of "0") to bridge and roll onto their side, and requires minimal assistance and/or supervision with sitting from lying supine.
  • Able (score of "1") to bridge, unable to roll onto their side (score of "0"), and requires minimal assistance and/or supervision with sitting from lying supine.
  • Capacity to provide consent, or have a surrogate decision-maker provide consent on their behalf.
  • Not near the end of life within three days of enrolment in the study.

Exclusion Criteria

  • Have a planned admission to another unit (including those identified as a setting for data collection in the study) within three days of enrolment in the study.
  • Sleep in a chair at night.
  • Whose clinical care would be negatively impacted if turned or repositioned.

Outcomes

Primary Outcomes

Interface pressure analysis - sensel pressure reading

Time Frame: 72 hours

Absolute number of sensels with pressure readings greater than 40 mmHg

Interface pressure analysis - % with pressure over 40mmHg

Time Frame: 72 hours

Proportion of participants that have pressure readings greater than 40 mmHg

Interface pressure analysis - peak pressure

Time Frame: 72 hours

Peak pressure of any given pressure reading sample

Interface pressure analysis - average pressure

Time Frame: 72 hours

Average interface pressure (excluding sensels with 0mmHg reading)

Secondary Outcomes

  • Pressure related skin and soft tissue changes(72 hours)
  • Perceptions of patients(72 hours)
  • Perceptions of healthcare providers(72 hours)

Study Sites (1)

Loading locations...

Similar Trials